CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Matrixx Initiatives, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Matrixx Initiatives, Inc.
1 Grande Commons
440 Route 22 East, Suite 130
Phone: (877) 942-2626p:877 942-2626 Bridgewater, NJ  08807  United States
This company was Merged or Acquired on 12/1/2020.
This company ceased filing statements with the SEC on 2/28/2011.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Matrixx Initiatives, Inc. is an OTC healthcare company that develops and markets Zicam® products. Zicam, LLC, its wholly-owned subsidiary, markets and sells Zicam® products in the cough and cold category. The Company markets Zicam brand homeopathic and allopathic OTC products, including Zicam Cold Remedy in multiple oral delivery forms; as well as Zicam Allergy and Congestion Relief products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20103/31/2010YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8062 General medical and surgical hospitals

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board William C.Egan 67 1/1/2009 8/30/2001
President, Chief Executive Officer, Director William J.Hemelt 58 8/28/2009 6/1/1998
Executive Vice President - Business Development, General Counsel, Secretary, Director Samuel C.Cowley 54 5/1/2008 7/18/2005
7 additional Officers and Directors records available in full report.

Business Names
Business Name
Zicam Canada, Inc.
Zicam Swab Products, LLC
Zicam, LLC

General Information
Stock Exchange: NASD
Federal Tax Id: 870482806
Email Address: info@matrixxinc.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023